InvestorsHub Logo
Followers 104
Posts 4948
Boards Moderated 0
Alias Born 10/20/2015

Re: nidan7500 post# 137222

Saturday, 01/13/2018 9:09:53 AM

Saturday, January 13, 2018 9:09:53 AM

Post# of 465195
I believe Anavex can go for a something like a "rolling approval" in ALZ by first showing insomnia and mood improvement. Recieve approval for that then following these patients and measuring other improvements in those patients as well as the ones formally in the trial to support an expanding label for A2-73 if other improvements are seen beyond the symptomatic improvements in sleep ,mood and others symptoms.
Make in effect a trial that started with a small n into one of a large n by following patients taking A2-73 Phase 4 style.
A limited label for symptoms only would make A2-73 a major blockbuster and provide much relief from suffering for ALZ victims and their caregivers.

I believe the language of the FDA you quoted supports this.

Take a guess what might happen to AVXL stock price when it is announced that the FDA agreed with such a plan and Anavex announces that is how they will proceed.
Long Anavex.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News